J7634 Budesonide comp con

Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 0 units per day (practitioner), rationale: Compounded Drug Policy